Reference Intervals Established for Serum Ferritin in Chinese Adults
By LabMedica International staff writers Posted on 12 Nov 2019 |

Image: The Abbott Architect i2000SR immunoassay analyzer (Photo courtesy of Abbott Diagnostics).
As the foundation for the interpretation of medical laboratory data, reference intervals (RIs) for analytes are one of the most widely used clinical decision‐making tool. Nevertheless, although measurement of serum ferritin (SF) has largely replaced laboratory assays of serum iron and transferrin or total iron‐binding capacity in clinical practice, there is no gold‐standard method for measuring SF.
At present, SF can be measured using immunoassays, for example, enzyme‐linked immunosorbent assay (ELISA), electrochemiluminescent immunoassay (ECLIA), chemiluminescent immunoassay (CLIA), or immunoturbidimetric assay. Normally, a small amount of ferritin exists in the peripheral circulating blood and is called serum ferritin.
Clinical Laboratory Scientists at the Shaoxing Hospital of China Medical University (Shaoxing, China PR) obtained the SF test results of all health examinees (8,913 males aged 18‐93 years and 5,397 females aged 18‐90 years) between December 2010 and April 2019 from their laboratory information system. Venous blood samples were obtained from each study participant after a 12‐hours fasting period and collected into BD vacutainer tubes (Becton Dickinson, Franklin Lakes, NJ, USA).
Serum was separated from the blood by centrifugation at 3,000 rpm for 5 minutes at room temperature (18‐25°C). All specimens were quantitatively determined within two hours of collection on an Abbott Architect i2000SR analyzer (Abbott Diagnostics, Chicago, IL, USA) according to the manufacturer's specifications and following the laboratory standard operating procedures. The detection kits and calibrators were provided by Abbott Diagnostics.
The scientists reported that SF levels in females were significantly different from those in males and showed a weak positive correlation with age. The RIs based on parametric approach in males were 66.12‐561.58 µg/L, whereas in all females were 3.59‐269.59 µg/L, females aged <50 years 3.26‐148.02 µg/L and those aged ≥50 years 17.28‐303.27 µg/L. The RIs based on non‐parametric approach in males were 65.00‐571.37 µg/L whereas in all females were 4.00‐254.00 µg/L, females aged <50 years 4.00‐152.00 µg/L and those aged ≥50 years 16.00‐304.05 µg/L.
The authors concluded that the present study has provided evidence that the RIs for SF in Chinese adults are markedly different from the manufacturer's recommended Rls. In Chinese adult females, the age‐specific RIs must be also taken into account. As a result, the establishment of the sex‐ and age‐specific RIs by indirect method using the data from health examination records for SF in their own laboratory would give a better chance to aid the physician in differentiating or considering treatment of iron‐deficiency anemia or a risk of iron overload than using manufacturer's recommended RIs or adopting RIs from other laboratories. The study was published on November 1, 2019 in the Journal of Clinical Laboratory Analysis.
Related Links:
Shaoxing Hospital of China Medical University
Becton Dickinson
Abbott Diagnostics
At present, SF can be measured using immunoassays, for example, enzyme‐linked immunosorbent assay (ELISA), electrochemiluminescent immunoassay (ECLIA), chemiluminescent immunoassay (CLIA), or immunoturbidimetric assay. Normally, a small amount of ferritin exists in the peripheral circulating blood and is called serum ferritin.
Clinical Laboratory Scientists at the Shaoxing Hospital of China Medical University (Shaoxing, China PR) obtained the SF test results of all health examinees (8,913 males aged 18‐93 years and 5,397 females aged 18‐90 years) between December 2010 and April 2019 from their laboratory information system. Venous blood samples were obtained from each study participant after a 12‐hours fasting period and collected into BD vacutainer tubes (Becton Dickinson, Franklin Lakes, NJ, USA).
Serum was separated from the blood by centrifugation at 3,000 rpm for 5 minutes at room temperature (18‐25°C). All specimens were quantitatively determined within two hours of collection on an Abbott Architect i2000SR analyzer (Abbott Diagnostics, Chicago, IL, USA) according to the manufacturer's specifications and following the laboratory standard operating procedures. The detection kits and calibrators were provided by Abbott Diagnostics.
The scientists reported that SF levels in females were significantly different from those in males and showed a weak positive correlation with age. The RIs based on parametric approach in males were 66.12‐561.58 µg/L, whereas in all females were 3.59‐269.59 µg/L, females aged <50 years 3.26‐148.02 µg/L and those aged ≥50 years 17.28‐303.27 µg/L. The RIs based on non‐parametric approach in males were 65.00‐571.37 µg/L whereas in all females were 4.00‐254.00 µg/L, females aged <50 years 4.00‐152.00 µg/L and those aged ≥50 years 16.00‐304.05 µg/L.
The authors concluded that the present study has provided evidence that the RIs for SF in Chinese adults are markedly different from the manufacturer's recommended Rls. In Chinese adult females, the age‐specific RIs must be also taken into account. As a result, the establishment of the sex‐ and age‐specific RIs by indirect method using the data from health examination records for SF in their own laboratory would give a better chance to aid the physician in differentiating or considering treatment of iron‐deficiency anemia or a risk of iron overload than using manufacturer's recommended RIs or adopting RIs from other laboratories. The study was published on November 1, 2019 in the Journal of Clinical Laboratory Analysis.
Related Links:
Shaoxing Hospital of China Medical University
Becton Dickinson
Abbott Diagnostics
Latest Hematology News
- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
- Personalized CBC Testing Could Help Diagnose Early-Stage Diseases in Healthy Individuals
- Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma
- First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC
- Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
- Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
- Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
- Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere
- New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more